| Phase 01 trial |
|
Phase 0
|
NCT01209676 |
Sep 2010 → Mar 2013 |
melanoma |
University of Pennsylvania |
Completed
|
No outcome recorded
|
| Phase 11 trial |
|
Phase 1
|
NCT01211262 |
Sep 2010 → Feb 2016 |
melanoma |
Immunocore Ltd |
Completed
|
No outcome recorded
|
| Phase 1/24 trials |
|
Phase 1/2
|
NCT06626516 |
Oct 2025 → Oct 2030 expected |
uveal melanoma |
Thomas Jefferson University |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT04262466 |
Feb 2020 → Oct 2026 expected |
cancer |
Immunocore Ltd |
Active not recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT02570308 |
Feb 2016 → Mar 2020 |
uveal melanoma |
Immunocore Ltd |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT02535078 |
Nov 2015 → Jun 2023 |
melanoma |
Immunocore Ltd |
Withdrawn
|
No outcome recorded
|
| Phase 29 trials |
|
Phase 2
|
NCT07276386 |
Dec 2025 → Dec 2030 expected |
uveal melanoma |
H. Lee Moffitt Cancer Center and Research Institute |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06942442 |
Oct 2025 → Oct 2030 expected |
MHC class I deficiency 2, clear cell sarcoma |
Sarcoma Alliance for Research through Collaboration |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06414590 |
Sep 2025 → Aug 2027 expected |
uveal melanoma |
Thomas Jefferson University |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06070012 |
Aug 2025 → Sep 2028 expected |
uveal melanoma |
Diwakar Davar |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07057596 |
Jul 2025 → Dec 2027 expected |
uveal melanoma |
Spanish Melanoma Group |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06627244 |
Feb 2025 → Feb 2028 expected |
uveal melanoma |
University of Miami |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05315258 |
Jul 2022 → Dec 2026 expected |
cutaneous melanoma, uveal melanoma |
University of Oxford |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT03070392 |
Oct 2017 → Oct 2020 |
uveal melanoma |
Immunocore Ltd |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT02889861 |
Jan 2017 → Apr 2019 |
melanoma |
Immunocore Ltd |
Terminated
|
No outcome recorded
|
| Phase 32 trials |
|
Phase 3
|
NCT06246149 |
Nov 2024 → Nov 2032 expected |
uveal melanoma |
European Organisation for Research and Treatment of Cancer - EORTC |
Recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT05549297 |
Dec 2022 → Mar 2028 expected |
melanoma |
Immunocore Ltd |
Recruiting
|
No outcome recorded
|
| Phase not stated1 trial |
| — |
NCT04960891 |
— |
uveal melanoma |
Immunocore Ltd |
Available
|
No outcome recorded
|